Clinical advances in hematology & oncology : H&O.
|
Implications of the Mechanism of Action of Regorafenib for Clinical Practice.
|
Prager G1 |
 Author information
1Department of Medicine I, Division of Oncology, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria.
|
Publikations ID: 32720933
Quelle: öffnen
|